United States Monogenetic Disorders Testing Market was valued at USD 1.8 Billion in 2022 and is projected to reach USD 4.1 Billion by 2030, growing at a CAGR of 11.1% from 2024 to 2030.
The US Monogenetic Disorders Testing Market has witnessed significant growth in recent years as advancements in genetic research and diagnostics continue to push the boundaries of healthcare. Monogenetic disorders, caused by mutations in a single gene, are being more frequently diagnosed with cutting-edge testing technologies, allowing healthcare providers to offer targeted treatments and personalized care. These disorders, ranging from cystic fibrosis to sickle cell anemia, require precise genetic testing to manage symptoms and predict future health risks.
The market for genetic testing in the United States is driven by several factors, including increased awareness, technological advancements, and the growing demand for personalized medicine. As more individuals seek information about their genetic makeup to predict potential health risks, the demand for monogenetic disorder testing rises. In 2023 alone, the genetic testing market in the US reached an estimated value of $10 billion, with monogenetic disorder testing contributing a significant portion of this revenue.
Leading companies in the testing market focus on offering a range of services, including whole genome sequencing, PCR-based diagnostics, and advanced CRISPR gene-editing technologies. As these technologies become more affordable and accessible, the market is expected to continue expanding. Additionally, initiatives aimed at enhancing patient awareness and increasing genetic literacy play a crucial role in pushing the demand for such testing services.
Another factor contributing to the growth of the US Monogenetic Disorders Testing Market is the shift toward preventative healthcare. Individuals are increasingly turning to genetic testing to identify inherited conditions before symptoms appear. This proactive approach allows for earlier intervention, potentially saving lives and reducing healthcare costs in the long run.
Furthermore, the integration of artificial intelligence (AI) and big data analytics in genetic testing is set to revolutionize the industry. AI algorithms are being developed to predict genetic mutations and assess the likelihood of developing certain disorders, adding a layer of precision to diagnostics. The growing adoption of AI-driven tools in genetic research will likely accelerate the market's growth in the coming years.
The future of monogenetic disorder testing in the US is poised for continued growth. With advancements in technology, increased demand for genetic information, and a stronger focus on personalized medicine, the market is expected to evolve rapidly. Consumers' growing interest in proactive healthcare and genetic testing, alongside cutting-edge innovations, will continue driving the market's expansion. The market, closely linked to fields like the "100 Gigabit Fiber Optic Transceiver Market", is poised to integrate new technologies that promise improved accuracy and faster results.
Get an In-Depth Research Analysis of the US Monogenetic Disorders Testing Market Size And Forecast [2025-2032]
Celera Group
Abbott
Thermo Fisher Scientific
ELITech Group
Quest
AutoGenomics
PerkinElmer
Roche
Bio-Rad
Transgenomic
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Monogenetic Disorders Testing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Monogenetic Disorders Testing Market
Targeted Gene Panels
Whole Exome Sequencing (WES)
Whole Genome Sequencing (WGS)
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Cystic Fibrosis
Sickle Cell Disease
Huntington's Disease
Duchenne Muscular Dystrophy
Tay-Sachs Disease
Hospitals
Diagnostic Laboratories
Research Institutions
Home Healthcare
Pharmaceutical Companies
Blood Samples
Saliva Samples
Tissue Biopsies
Amniotic Fluid
Chorionic Villus Sampling (CVS)
Newborn Screening
Carrier Screening
Preconception Testing
Diagnostic Testing
Prenatal Testing
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Monogenetic Disorders Testing Market Research Analysis
1. Introduction of the US Monogenetic Disorders Testing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Monogenetic Disorders Testing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Monogenetic Disorders Testing Market, By Type
6. US Monogenetic Disorders Testing Market, By Application
7. US Monogenetic Disorders Testing Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Monogenetic Disorders Testing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/